COMPANY
FAScinate Therapeutics
Timeline
- Trial start Phase 2: A Study to Evaluate Safety and Efficacy of KM-819 in Healthy Adults and Participants with Parkinson's Disease source ↗
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT05670782 | A Study to Evaluate Safety and Efficacy of KM-819 in Healthy Adults and Participants with Parkinson's Disease | Phase 2 | Unknown status (ClinicalTrials.gov) | Jul 19, 2022 | Oct 30, 2025 (estimated) |